NASDAQ | TSX: ACB
- Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY
- Generates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoY
- Achieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1
- Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2
EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter fiscal 2025.
“This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue1, net income, adjusted EBITDA1, and free cash flow1. These achievements, along with our strong cash…
